Finance

Lists
MEGA:BKK
Mega Lifesciences PCL
32,75 ฿
-0,76%
(-0,25) 1D
14-окт., 16:40:00 GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for MEGA...
Open
33,00 ฿
High
33,25 ฿
Low
32,75 ฿
Mkt. cap
28,77 млд
Avg. vol.
783,01 миң
Volume
1,32 млн
52-wk high
40,00 ฿
52-wk low
27,75 ฿
Shares outstanding
871,87 млн
No. of employees
5 миң
Open
33,00 ฿
High
33,25 ฿
Low
32,75 ฿
Mkt. cap
28,77 млд
Avg. vol.
783,01 миң
Volume
1,32 млн
52-wk high
40,00 ฿
52-wk low
27,75 ฿
Shares outstanding
871,87 млн
No. of employees
5 миң
News stories
From web sources and news partners
About Mega Lifesciences PCL
CEOVivek Dhawan
Employees5,4 миң
Founded1982
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in THB
Loading Previous Earnings...
Revenue
Net income
All values in THB
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,89 млд
3,67 млд
3,42 млд
3,55 млд
Cost of goods sold
1,85 млд
1,71 млд
1,62 млд
1,71 млд
Cost of revenue
1,85 млд
1,71 млд
1,62 млд
1,71 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,10 млд
1,17 млд
1,05 млд
1,24 млд
Operating expense
1,10 млд
1,17 млд
1,05 млд
1,24 млд
Total operating expenses
2,95 млд
2,88 млд
2,67 млд
2,94 млд
Operating income
935,02 млн
790,27 млн
743,68 млн
603,68 млн
Other non operating income
-
-
-
-
EBT including unusual items
623,30 млн
739,13 млн
779,88 млн
664,13 млн
EBT excluding unusual items
623,30 млн
739,13 млн
779,88 млн
664,13 млн
Income tax expense
129,09 млн
162,16 млн
175,28 млн
149,59 млн
Effective tax rate
20,71%
21,94%
22,47%
22,52%
Other operating expenses
-
-
-
-
Net income
494,19 млн
577,04 млн
604,52 млн
514,61 млн
Net profit margin
12,71%
15,71%
17,69%
14,51%
Earnings per share
0,57
0,69
0,65
0,54
Interest and investment income
20,17 млн
26,41 млн
18,33 млн
21,17 млн
Interest expense
-15,08 млн
-17,55 млн
-14,84 млн
-11,95 млн
Net interest expenses
5,09 млн
8,87 млн
3,50 млн
9,22 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
987,93 млн
838,04 млн
792,46 млн
654,08 млн
Gain or loss from assets sale
-696,00 миң
-1,47 млн
-113,00 миң
60,00 миң
AI content may include mistakes. Learn more
Google колдонмолору